Markus J. Cappel, Chief Business Officer & Treasurer at ChemoCentryx, Inc. (CCXI), sold 700 shares at $69.66 ($49K) on 2021-02-09, disclosed to the SEC on 2021-02-11.
Scheduled sale ($49k) by Chief Business Officer & Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CCXI | SELL | 2021-02-08 | $1.2M | — | Filing → |
| CCXI | SELL | 2021-01-27 | $184K | — | Filing → |
| CCXI | SELL | 2020-06-16 | $4.4M | — | Filing → |